KLTO
Price:
$0.381
Market Cap:
$20.93M
Klotho Neurosciences, Inc. operates as a biopharmaceutical enterprise focused on devising medical treatments for various conditions, including cancer, cardiovascular ailments, and neurodegenerative disorders. Their leading gene therapy assets encompass AMI-101, which is designed for the management or prevention of Alzheimer's disease, and AMI-202, aimed at treating or averting amyotrophic lateral sclerosis. Formerly known as Anew Medical, Inc., the company underwent a name change to Klotho Neurosciences, Inc. in September 2024. The firm's main office is situated in Omaha, Nebraska.
Industry
Biotechnology
IPO Date
2022-04-29
Stock Exchange
NASDAQ
Ticker
KLTO
According to Klotho Neurosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 95.01. This represents a change of 20.76% compared to the average of 78.68 of the last 4 quarters.
The mean historical Current Ratio of Klotho Neurosciences, Inc. over the last ten years is 24.00. The current 95.01 Current Ratio has changed 39.48% with respect to the historical average. Over the past ten years (40 quarters), KLTO's Current Ratio was at its highest in in the June 2025 quarter at 135.74. The Current Ratio was at its lowest in in the March 2024 quarter at 0.00.
Average
24.00
Median
0.50
Minimum
0.00
Maximum
95.01
Discovering the peaks and valleys of Klotho Neurosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 75.01%
Maximum Annual Current Ratio = 95.01
Minimum Annual Increase = -99.53%
Minimum Annual Current Ratio = 0.00
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 95.01 | 75.01% |
| 2024 | 0.13 | 2.98% |
| 2023 | 0.00 | -99.53% |
The current Current Ratio of Klotho Neurosciences, Inc. (KLTO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
31.72
5-year avg
24.00
10-year avg
24.00
Klotho Neurosciences, Inc.’s Current Ratio is greater than Cadrenal Therapeutics, Inc. Common Stock (2.68), greater than Rallybio Corporation (12.92), greater than Exicure, Inc. (0.79), greater than Minerva Neurosciences, Inc. (17.65), greater than iBio, Inc. (11.88), greater than NeuroSense Therapeutics Ltd. (0.31), greater than Sonnet BioTherapeutics Holdings, Inc. (3.50), greater than TAO Synergies Inc. (27.40), greater than MetaVia Inc. (2.73), greater than NeurAxis, Inc. (2.89),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.68 | $10.61M | |
| 12.92 | $84.35M | |
| 0.79 | $17.72M | |
| 17.65 | $31.54M | |
| 11.88 | $26.68M | |
| 0.31 | $18.13M | |
| 3.50 | $8.43M | |
| 27.40 | $11.90M | |
| 2.73 | $3.83M | |
| 2.89 | $82.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Klotho Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Klotho Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Klotho Neurosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Klotho Neurosciences, Inc. (KLTO)?
What is the highest Current Ratio for Klotho Neurosciences, Inc. (KLTO)?
What is the 3-year average Current Ratio for Klotho Neurosciences, Inc. (KLTO)?
What is the 5-year average Current Ratio for Klotho Neurosciences, Inc. (KLTO)?
How does the current Current Ratio for Klotho Neurosciences, Inc. (KLTO) compare to its historical average?